Efficacy and Safety of Jiawei Suanzaoren Decoction Combined with Lorazepam for Chronic Insomnia: A Parallel-Group Randomized Controlled Trial
Table 3
Sleep diary parameters in both groups.
Group
Time
SOL (min)
TST (min)
NNTA (n)
TG
Baseline
67.4 ± 26.27
192.2 ± 54.14
3.3 ± 1.27
4-week
38.4 ± 10.86
312.5 ± 47.59
2.8 ± 1.45
8-week
28.2 ± 7.05
329.5 ± 41.46
2.6 ± 1.16
12-week
22.0 ± 4.14
378.8 ± 53.03
2.3 ± 1.15
F value of ANOVA
5.34
7.49
2.03
value
0.001
0.0001
0.11
CG
Baseline
75.6 ± 23.27
182.7 ± 51.04
3.9 ± 1.83
4-week
45.9 ± 13.93
223.9 ± 55.6
3.2 ± 1.68
8-week
36.5 ± 13.19
337.2 ± 47.88
2.8 ± 1.13
12-week
29.1 ± 6.67
368.7 ± 72.86
2.6 ± 1.41
F value of ANOVA
4.28
5.72
1.67
P value
0.005
0.001
0.17
Cohen’s d
1.28
0.16
0.23
Data were expressed as mean ± SD. TG: the treatment group, CG: the control group. SOL: sleep onset latency; TST: total sleep time; NNTA: the number of night-time awakenings. and when compared with baseline in the same group. and when compared with CG at the same observation point.
